When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Alcohol use disorder

最后审阅: 15 Oct 2025
最后更新: 25 Sep 2025

小结

定义

病史和体格检查

关键诊断因素

  • withdrawal
  • tolerance
  • increased/decreased liver size, jaundice, ascites
完整详情

其他诊断因素

  • insomnia
  • erectile dysfunction
  • nicotine use disorder
  • gastrointestinal distress
  • muscle cramps, pain, tenderness, altered sensory perception
  • hypertension and tachycardia
  • impaired nutritional status
  • broad-based gait
完整详情

危险因素

  • family history of alcohol use disorder
  • depression, anxiety, and other mental health disorders
  • socioeconomic deprivation
  • lack of facial flushing on exposure to alcohol
  • low responsivity to the effects of alcohol
  • history of gastric bypass
完整详情

诊断性检查

首要检查

  • diagnostic interview
  • alcohol level (breath and blood)
  • Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar)
完整详情

需考虑的检查

  • carbohydrate-deficient transferrin (CDT)
  • gamma glutamyl transpeptidase (gamma-GT), alanine aminotransferase (ALT), aspartate aminotransferase (AST)
  • CBC
  • urinary ethyl glucuronide
  • phosphatidylethanol (PEth)
完整详情

治疗流程

持续性治疗

at-risk drinking

alcohol use disorder: nonpregnant adult with no concurrent opioid use or mental health diagnosis

alcohol use disorder: nonpregnant adult with concurrent opioid use

alcohol use disorder: nonpregnant adult with concurrent mental health diagnosis

alcohol use disorder: nonpregnant adolescent

alcohol use disorder: pregnant

撰稿人

作者

Elisabeth Poorman, MD, MPH

Assistant Professor of Medicine

Department of Medicine

University of Illinois Chicago

Chicago

IL

利益声明

EP declares that she has no conflicting interests.

Marlene Martin, MD

Associate Professor of Clinical Medicine

Director, Addiction Care Team

San Francisco General Hospital

University of California, San Francisco

San Francisco

CA

利益声明

MM is a board member for the National Harm Reduction Coalition and has done consultancy work for the Society of Hospital Medicine.

Sarah Messmer, MD

Assistant Professor of Clinical Medicine and Pediatrics

University of Illinois Chicago

Chicago

IL

利益声明

SM declares that she has no conflicting interests.

鸣谢

Dr Elisabeth Poorman, Dr Marlene Martin, and Dr Sarah Messmer would like to gratefully acknowledge Dr Colin Drummond, Dr Julie R. Pittman, Dr Philip H. Chung, Dr Robert M. Swift, and Dr Lorenzo Leggio, previous contributors to this topic.

利益声明

CD, JRP, PHC, and RMS declare that they have no competing interests. LL is an author of a reference cited in this topic.

同行评议者

Stephen Holt, MD, MS

Associate Professor of Medicine

Yale School of Medicine

New Haven

CT

利益声明

SH declares that they have no competing interests.

Bhanu Prakash Kolla, MD, FRCPsych

Professor of Psychiatry

Department of Psychiatry and Psychology

Addiction Psychiatrist and Sleep Physician

Center for Sleep Medicine, Mayo Clinic

Rochester

MN

利益声明

BPK declares that they have no competing interests.

Paul S. Haber, MD

Royal Prince Alfred Hospital and Discipline of Medicine

University of Sydney

Sydney

Australia

利益声明

PSH is an author of a reference cited in this topic.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

American Society of Addiction Medicine. Engagement and retention of nonabstinent patients in substance use treatment: clinical consideration for addiction treatment providers. Oct 2024 [internet publication].全文

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

World Health Organization. International classification of diseases,​ 11th revision (ICD-11). Feb 2025 [internet publication].全文

US Department of Veterans Affairs. VA/DOD clinical practice guidelines: management of substance use disorders. 2021​ [internet publication].全文

Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • 鉴别诊断

    • Other psychiatric disorders
    • Other substance use disorders (especially sedatives)
    更多 鉴别诊断
  • 指南

    • Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR)
    • Management of substance use disorders: guidelines from the VA/DoD
    更多 指南
  • 患者教育信息

    Alcohol-use disorder

    更多 患者教育信息
  • 医学计算器

    Alcohol Consumption Screening AUDIT Questionnaire

    更多 医学计算器
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明